Boutique draft picks for 2023-24
New biotech/pharma names to watch this year
Below are a few names we’re closely monitoring ($CERE, $KRTX, $ADXN, $LIFE), each divided into a different segment.
Value: Atyr Pharma (LIFE)
Atyr Pharma is currently enrolling for a pivotal Phase 3 in pulmonary sarcoidosis, the most prevalent immune-mediated fibrotic lung disease. This is an inflammatory disease in the lungs that forms granulomas and can…